Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Dead Zone
    • Deadly Denials
    • Diagnosis: Debt
    • Guns, Race, and Profit
    • Overpayment Outrage
    • Payback: Tracking Opioid Cash
    • Priced Out
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Date
Custom Date Range
Topic
Content Type

Showing 4821-4840 of 131,637 results

Perspectives: Drug Price Policy May Lift Costs For Some; To Lower Prescription Prices, Competition Is Key

October 9, 2024 Morning Briefing

Read recent commentaries about pharmaceutical issues.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Viewpoints: Has Obesity Rate Finally Plateaued?; Doctors Can Regain Trust By Saying ‘I Don’t Know’

October 9, 2024 Morning Briefing

Editorial writers tackle these public health issues.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

45% Of Americans Struggle To Afford Health Care Across The States: Map

October 9, 2024 Morning Briefing

Nearly 1 in 3 Americans — in the only wealthy country in the world to not have a developed universal health care system — lack reliable primary care access. Meanwhile, unlike JD Vance, Americans are getting shorter due in part to poor access to quality health care and nutrition.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Insurers To Shift A Bit From Medicare Advantage To Special Needs Plans

October 9, 2024 Morning Briefing

Health insurance companies are expected to pull back slightly from Medicare Advantage investing in 2025. Instead, Modern Healthcare reports, they will focus on Dual-Eligible Special Needs Plans, or D-SNPs, which cover people who are eligible for both Medicare and Medicaid. Other industry news is on employer plans, executive jobs, and more.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Meth Use Cited As A Factor In 1 In 5 Heat-Related Deaths In US

October 9, 2024 Morning Briefing

In southwestern states that routinely see sweltering temperatures, the stimulant was found in a third of heat deaths in 2023. Also, the successes and setbacks of modern medicine.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Medicare To Announce Pilot Program That Offers Some Generic Drugs For $2

October 9, 2024 Morning Briefing

Axios reports the Biden administration today will release a preliminary list of generic drugs for Medicare recipients that would cost no more than $2 out of pocket. The pilot program aims to test drug adherence and health outcomes.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Oropouche Virus Lingers In Semen For Over 2 Weeks, Scientists Find

October 9, 2024 Morning Briefing

A new study discovered that live virus replication was detectable in semen in a patient infected with Oropouche virus some 16 days after symptom onset, suggesting a risk of sexual transmission. Separately, tickborne babesiosis is on the rise.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Mifepristone Maker To Seek FDA OK For Use Of Drug To Treat Miscarriages

October 9, 2024 Morning Briefing

The Wall Street Journal reports that Danco, the pharmaceutical company that makes mifepristone under the label Mifeprex, plans to apply for FDA approval for use of the drug in managing miscarriages. If approved the drug could become more widely available, when its use is already under legal challenge as part of a medication abortion protocol.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Lawsuit Triggered As FDA Declares End Of Mounjaro, Zepbound Shortage

October 9, 2024 Morning Briefing

Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the “copycat” drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes compound version of the drug for participants in its programs.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Morning Briefing for Wednesday, October 9, 2024

October 9, 2024 Morning Briefing

Drug overdoses, health care affordability, Medicare coverage, election news, extreme weather’s industry impact, vaccines, and more

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Harris Proposes Home Health Care Expansion Under Medicare

October 9, 2024 Morning Briefing

Vice President Kamala Harris says if elected president she will push for increased Medicare coverage of long-term care services in the home for aging patients. Her campaign also talked about drug prices and PBMs Tuesday; the New York Times compares the presidential candidates’ positions on the issue.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Baxter Restarts Shipping IV Products As Hospitals Cope With Shortage

October 9, 2024 Morning Briefing

The company is leaning on its global plants to help meet production demands after its Helene-damaged facility in North Carolina temporarily shut down. Meanwhile, hospitals, health care facilities, and workers in Florida prepare for Hurricane Milton’s direct hit.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

GSK’s Widely Used RSV Shot Retains 43% Potency In Third Year, Data Show

October 9, 2024 Morning Briefing

Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen Rapid Check COVID-19/Flu A&B Antigen Test can give you results in 15 minutes.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

First Edition: Wednesday, Oct. 9, 2024

October 9, 2024 Morning Briefing

Today’s early morning highlights from the major news organizations.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
An illustration of a white mug with an orange poppy flower decoration on the side. Steam is wafting from the tea in the mug.

Poppy Seed Brew Triggers Morphine Overdose, Drawing Attention of Lawmakers

By David Hilzenrath Illustration by Lydia Zuraw October 9, 2024 KFF Health News Original

Poppy seeds contaminated with opioids can be used to make a deadly brew, a watchdog says.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
A photo of opened orange pill bottles arranged on a table.

Employers Haven’t a Clue How Their Drug Benefits Are Managed

By Arthur Allen October 9, 2024 KFF Health News Original

The Big Three pharmacy benefit managers say they return nearly all the rebates they get from drugmakers to the employers and insurers who hire them. But most employers seem to doubt that.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

An Arm and a Leg: ‘Baby Steps’ in the Fight Against Facility Fees

By Dan Weissmann October 9, 2024 Podcast

An extra $99 fee on top of a copay for a checkup didn’t sit right with a listener. Turns out, state legislators across the country aren’t buying it either.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
A photo of a woman sitting at a desk, working at a computer.

Asian Health Center Tries Unconventional Approach to Counseling

By Sarah Kwon October 9, 2024 KFF Health News Original

Facing a dire shortage of bilingual and culturally attuned therapists, an Oakland, California, community clinic serving Asian immigrants has trained staffers in a victim support unit to provide lay counseling.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

Calif. Ballot Measure Targets Drug Discount Program Spending

By Angela Hart October 8, 2024 KFF Health News Original

Californians in November will weigh in on a ballot initiative to increase scrutiny over the use of health-care dollars — particularly money from a federal drug discount program — meant to support patient care largely for low-income or indigent people. The revenue is sometimes used to address housing instability and homelessness among vulnerable patient populations. Voters […]

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

‘Silence In Sikeston’ Podcast Finale: How Do You Build Trust?

October 8, 2024 Morning Briefing

Our “Silence in Sikeston” project, a multimedia collaboration from KFF Health News, Retro Report, and WORLD, explores the impact of a 1942 lynching and a 2020 police shooting on a rural Missouri community. Today, Episode 4 of our podcast explores the promise of systemic change and structural fixes for racism.

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
  • Previous
  • 240
  • 241
  • 242
  • 243
  • 244
  • Next

More From KFF Health News

A man with muscular dystrophy works at a desk with multiple computer monitors.

Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota

Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles

An elderly woman takes her blood pressure at home. Unrecognizable person, hand close-up.

‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control

A woman in a yellow cardigan sits in front of a window, staring out

Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue